Lee Hatter, Pepa Bruce, Mark Holliday, Augustus J Anderson, Irene Braithwaite, Andrew Corin, Allie Eathorne, Arthur Grimes, Matire Harwood, Thomas Hills, Ciléin Kearns, Kyley Kerse, John Martindale, Barney Montgomery, Lynn Riggs, Davitt Sheahan, Nick Shortt, Katja Zazulia, Mark Weatherall, David McNamara, Catherine A Byrnes, Andrew Bush, Stuart R Dalziel, Richard Beasley
BACKGROUND: Asthma is the most common chronic disease in children, many of whom are managed solely with a short-acting β2 -agonist (SABA). In adults, the evidence that budesonide-formoterol as sole reliever therapy markedly reduces the risk of severe exacerbations compared with SABA alone has contributed to the Global Initiative for Asthma recommending against SABA monotherapy in this population. The current lack of evidence in children means it is unknown whether these findings are also relevant to this demographic...
October 2021: ERJ Open Research